Hepatotoxicity induced by clopidogrel [2]

Journal of Hepatology

Volumn 40, Issue 3, 2004, Pages 560-562

  Beltran Robles, M ^a   Marquez Saavedra, E ^a   Sanchez Munoz D ^a   Romero Gomez, M ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CAPTOPRIL; CARVEDILOL; CLOPIDOGREL; ENOXAPARIN; NITRITE; OMEPRAZOLE;

ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TREATMENT WITHDRAWAL; ULTRASOUND;

EID: 1242292345     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.11.013     Document Type: Letter

References (9)

1. Lee W.M. Drug-induced hepatotoxicity. N Engl J Med. 349:2003;474-485.
2. Savi P., Combalbert J., Gaich C., et al. Clopidogrel: pharmacodynamics, metabolic activation by cytochrome P450-1A animal study. Thromb Haemost. 72:1994;313-317.
3. Duran Quintana J.A., Jiménez Saenz M., Montero A.R., Herrerías Gutierrez M. Clopidogrel probably induced hepatic toxicity. Med Clin (Barc). 119:2002;37.
4. Willens H.J. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther. 7:2000;317-318.
5. Romero-Gomez M., Otero M.A., Suarez-Garcia E., Garcia-Diaz E., Fobelo M.J., Castro-Fernandez M. Acute hepatitis related to omeprazol. Am J Gastroenterol. 94:1999;1119-1120.
6. Perez Roldan F., Gonzalez Carro P.S., Legaz Huidobro M.L., Saez Bravo J.M., Ruiz Carrillo F. Cholestatic hepatitis caused by captopril. Rev Esp Enf Dig. 90:1998;378-379.
7. Hagmeyer K.O., Stein J. Hepatotoxicity associated with carvedilol. Ann Pharmacother. 35:2001;1364-1366.
8. Maria V.A.J., Victorino R.M.M. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 26:1997;664-669.
9. Naranjo C.A., Busto V., Sellers E.M., Sandor P., Ruiz I., Roberts E., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30:1981;239-245.